| Year |
Citation |
Score |
| 2023 |
Mancarella C, Giusti V, Caldoni G, Laginestra MA, Parra A, Toracchio L, Giordano G, Roncuzzi L, Piazzi M, Blalock W, Columbaro M, De Feo A, Scotlandi K. Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells. Cancer Gene Therapy. 30: 1285-1295. PMID 37353558 DOI: 10.1038/s41417-023-00637-8 |
0.337 |
|
| 2023 |
Salucci S, Bavelloni A, Stella AB, Fabbri F, Vannini I, Piazzi M, Volkava K, Scotlandi K, Martinelli G, Faenza I, Blalock W. The Cytotoxic Effect of Curcumin in Rhabdomyosarcoma Is Associated with the Modulation of AMPK, AKT/mTOR, STAT, and p53 Signaling. Nutrients. 15. PMID 36771452 DOI: 10.3390/nu15030740 |
0.477 |
|
| 2022 |
Piazzi M, Bavelloni A, Cenni V, Salucci S, Bartoletti Stella A, Tomassini E, Scotlandi K, Blalock WL, Faenza I. Combined Treatment with PI3K Inhibitors BYL-719 and CAL-101 Is a Promising Antiproliferative Strategy in Human Rhabdomyosarcoma Cells. Molecules (Basel, Switzerland). 27. PMID 35566091 DOI: 10.3390/molecules27092742 |
0.454 |
|
| 2021 |
Blalock WL. Opposing forces fight over the same ground to regulate interferon signaling. The Biochemical Journal. 478: 1853-1859. PMID 34003254 DOI: 10.1042/BCJ20210110 |
0.36 |
|
| 2021 |
Piazzi M, Kojic S, Capanni C, Stamenkovic N, Bavelloni A, Marin O, Lattanzi G, Blalock W, Cenni V. Ectopic Expression of Ankrd2 Affects Proliferation, Motility and Clonogenic Potential of Human Osteosarcoma Cells. Cancers. 13. PMID 33419058 DOI: 10.3390/cancers13020174 |
0.356 |
|
| 2020 |
Akula SM, Abrams SL, Steelman LS, Candido S, Libra M, Lerpiriyapong K, Cocco L, Ramazzotti G, Ratti S, Follo MY, Martelli AM, Blalock WL, Piazzi M, Montalto G, Cervello M, et al. Cancer therapy and treatments during COVID-19 era. Advances in Biological Regulation. 77: 100739. PMID 32773105 DOI: 10.1016/J.Jbior.2020.100739 |
0.438 |
|
| 2020 |
Piazzi M, Bavelloni A, Faenza I, Blalock W. Glycogen synthase kinase (GSK)-3 and the double-strand RNA-dependent kinase, PKR: When two kinases for the common good turn bad. Biochimica Et Biophysica Acta. Molecular Cell Research. 1867: 118769. PMID 32512016 DOI: 10.1016/J.Bbamcr.2020.118769 |
0.439 |
|
| 2020 |
Piazzi M, Bavelloni A, Gallo A, Blalock WL. AKT-Dependent Phosphorylation of ADAR1p110 and ADAR2 Represents a New and Important Link Between Cell Signaling and RNA Editing. Dna and Cell Biology. PMID 31999481 DOI: 10.1089/Dna.2020.5351 |
0.428 |
|
| 2020 |
Akula SM, Abrams SL, Steelman LS, Candido S, Libra M, Lerpiriyapong K, Cocco L, Ramazzotti G, Ratti S, Follo MY, Martelli AM, Blalock WL, Piazzi M, Montalto G, Cervello M, et al. Cancer therapy and treatments during COVID-19 era Advances in Biological Regulation. 77: 100739. DOI: 10.1016/j.jbior.2020.100739 |
0.353 |
|
| 2019 |
Piazzi M, Bavelloni A, Greco S, Focaccia E, Orsini A, Benini S, Gambarotti M, Faenza I, Blalock WL. Expression of the double-stranded RNA-dependent kinase PKR influences osteosarcoma attachment independent growth, migration, and invasion. Journal of Cellular Physiology. PMID 31240713 DOI: 10.1002/Jcp.29024 |
0.45 |
|
| 2019 |
Piazzi M, Bavelloni A, Gallo A, Faenza I, Blalock WL. Signal Transduction in Ribosome Biogenesis: A Recipe to Avoid Disaster. International Journal of Molecular Sciences. 20. PMID 31163577 DOI: 10.3390/Ijms20112718 |
0.429 |
|
| 2019 |
Bavelloni A, Focaccia E, Piazzi M, Raffini M, Cesarini V, Tomaselli S, Orsini A, Ratti S, Faenza I, Cocco L, Gallo A, Blalock WL. AKT-dependent phosphorylation of the adenosine deaminases ADAR-1 and -2 inhibits deaminase activity. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201800490RR. PMID 31095429 DOI: 10.1096/Fj.201800490Rr |
0.445 |
|
| 2018 |
Bavelloni A, Focaccia E, Piazzi M, Orsini A, Ramazzotti G, Cocco L, Blalock W, Faenza I. Therapeutic potential of nvp-bkm120 in human osteosarcomas cells. Journal of Cellular Physiology. 234: 10907-10917. PMID 30536897 DOI: 10.1002/Jcp.27911 |
0.576 |
|
| 2017 |
Bavelloni A, Focaccia E, Piazzi M, Errani C, Blalock W, Faenza I. Cell Cycle Arrest and Apoptosis Induced by Kinamycin F in Human Osteosarcoma Cells. Anticancer Research. 37: 4103-4109. PMID 28739694 DOI: 10.21873/Anticanres.11797 |
0.403 |
|
| 2017 |
Bavelloni A, Piazzi M, Ramazzotti G, Fiume R, Blalock W, Faenza I. PI3Kα-selective inhibitor alpelisib (BYL719), may be effective as anticancer agents in Rhabdomyosarcoma Italian Journal of Anatomy and Embryology. 122: 21. DOI: 10.13128/Ijae-21412 |
0.544 |
|
| 2016 |
Ramazzotti G, Bavelloni A, Blalock W, Piazzi M, Cocco L, Faenza I. BMP-2 Induced Expression of PLCβ1 That is a Positive Regulator of Osteoblast Differentiation. Journal of Cellular Physiology. 231: 623-9. PMID 26217938 DOI: 10.1002/Jcp.25107 |
0.376 |
|
| 2015 |
Bavelloni A, Piazzi M, Raffini M, Faenza I, Blalock WL. Prohibitin 2: At a communications crossroads. Iubmb Life. 67: 239-54. PMID 25904163 DOI: 10.1002/Iub.1366 |
0.367 |
|
| 2015 |
Piazzi M, Blalock WL, Bavelloni A, Faenza I, Raffini M, Tagliavini F, Manzoli L, Cocco L. PI-PLCβ1b affects Akt activation, cyclin E expression, and caspase cleavage, promoting cell survival in pro-B-lymphoblastic cells exposed to oxidative stress. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 29: 1383-94. PMID 25550457 DOI: 10.1096/Fj.14-259051 |
0.57 |
|
| 2015 |
Bavelloni A, Dmitrienko GI, Goodfellow VJ, Ghavami A, Piazzi M, Blalock W, Chiarini F, Cocco L, Faenza I. PLCβ1a and PLCβ1b selective regulation and cyclin D3 modulation reduced by kinamycin F during k562 cell differentiation. Journal of Cellular Physiology. 230: 587-94. PMID 25160985 DOI: 10.1002/Jcp.24776 |
0.395 |
|
| 2014 |
Bavelloni A, Poli A, Fiume R, Blalock W, Matteucci A, Ramazzotti G, McCubrey JA, Cocco L, Faenza I. PLC-beta 1 regulates the expression of miR-210 during mithramycin-mediated erythroid differentiation in K562 cells. Oncotarget. 5: 4222-31. PMID 24962066 DOI: 10.18632/Oncotarget.1972 |
0.531 |
|
| 2014 |
Bavelloni A, Piazzi M, Faenza I, Raffini M, D'Angelo A, Cattini L, Cocco L, Blalock WL. Prohibitin 2 represents a novel nuclear AKT substrate during all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 28: 2009-19. PMID 24522204 DOI: 10.1096/Fj.13-244368 |
0.531 |
|
| 2014 |
Blalock WL, Piazzi M, Bavelloni A, Raffini M, Faenza I, D'Angelo A, Cocco L. Identification of the PKR nuclear interactome reveals roles in ribosome biogenesis, mRNA processing and cell division. Journal of Cellular Physiology. 229: 1047-60. PMID 24347309 DOI: 10.1002/Jcp.24529 |
0.48 |
|
| 2014 |
Follo MY, Faenza I, Piazzi M, Blalock WL, Manzoli L, McCubrey JA, Cocco L. Nuclear PI-PLCβ1: an appraisal on targets and pathology. Advances in Biological Regulation. 54: 2-11. PMID 24296032 DOI: 10.1016/J.Jbior.2013.11.003 |
0.616 |
|
| 2014 |
Piazzi M, Bavelloni A, Blalock W, Faenza I. From interaction to function: Phospholipase C beta 1 protects cells from stress-induced apoptosis Italian Journal of Anatomy and Embryology. 119: 150. DOI: 10.13128/Ijae-15989 |
0.574 |
|
| 2013 |
Piazzi M, Blalock WL, Bavelloni A, Faenza I, D'Angelo A, Maraldi NM, Cocco L. Phosphoinositide-specific phospholipase C β 1b (PI-PLCβ1b) interactome: affinity purification-mass spectrometry analysis of PI-PLCβ1b with nuclear protein. Molecular & Cellular Proteomics : McP. 12: 2220-35. PMID 23665500 DOI: 10.1074/Mcp.M113.029686 |
0.391 |
|
| 2012 |
Faenza I, Blalock W, Bavelloni A, Schoser B, Fiume R, Pacella S, Piazzi M, D'Angelo A, Cocco L. A role for PLCβ1 in myotonic dystrophies type 1 and 2. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 3042-8. PMID 22459146 DOI: 10.1096/Fj.11-200337 |
0.404 |
|
| 2012 |
Blalock W, Cocco L. EIF2AK2 (eukaryotic translation initiation factor 2-alpha kinase 2) Atlas of Genetics and Cytogenetics in Oncology and Haematology. DOI: 10.4267/2042/47528 |
0.334 |
|
| 2012 |
Piazzi M, Bavelloni A, Blalock W, Fiume R, D’Angelo A, Matteucci A, Cocco L, Faenza I. Nuclear phospholipase Cβ1 interactome: a morphological and proteomic approach Italian Journal of Anatomy and Embryology. 117: 145. DOI: 10.13128/Ijae-12256 |
0.348 |
|
| 2011 |
Blalock WL, Bavelloni A, Piazzi M, Tagliavini F, Faenza I, Martelli AM, Follo MY, Cocco L. Multiple forms of PKR present in the nuclei of acute leukemia cells represent an active kinase that is responsive to stress. Leukemia. 25: 236-45. PMID 21072047 DOI: 10.1038/Leu.2010.264 |
0.454 |
|
| 2011 |
Bavelloni A, Faenza I, Piazzi M, Blalock W, D’Angelo A, Tagliavini F, Pinetti D, Matteucci S, Mariani GA, Cocco L. Identification of nuclear substrates of Akt/PKB by functional proteomics: prohibitin 2 is a target of Akt phosphorylation in human promyelocytic leukemia cells Italian Journal of Anatomy and Embryology. 116: 19. DOI: 10.13128/Ijae-9969 |
0.529 |
|
| 2010 |
Piazzi M, Bavelloni A, Faenza I, Blalock W, Urbani A, D'Aguanno S, Fiume R, Ramazzotti G, Maraldi NM, Cocco L. eEF1A phosphorylation in the nucleus of insulin-stimulated C2C12 myoblasts: Ser⁵³ is a novel substrate for protein kinase C βI. Molecular & Cellular Proteomics : McP. 9: 2719-28. PMID 20923971 DOI: 10.1074/Mcp.M110.003152 |
0.38 |
|
| 2010 |
Blalock WL, Bavelloni A, Piazzi M, Faenza I, Cocco L. A role for PKR in hematologic malignancies. Journal of Cellular Physiology. 223: 572-91. PMID 20232306 DOI: 10.1002/Jcp.22092 |
0.475 |
|
| 2009 |
Blalock WL, Grimaldi C, Fala F, Follo M, Horn S, Basecke J, Martinelli G, Cocco L, Martelli AM. PKR activity is required for acute leukemic cell maintenance and growth: a role for PKR-mediated phosphatase activity to regulate GSK-3 phosphorylation. Journal of Cellular Physiology. 221: 232-41. PMID 19507191 DOI: 10.1002/Jcp.21848 |
0.516 |
|
| 2008 |
Bennett RL, Blalock WL, Choi EJ, Lee YJ, Zhang Y, Zhou L, Oh SP, May WS. RAX is required for fly neuronal development and mouse embryogenesis. Mechanisms of Development. 125: 777-85. PMID 18634873 DOI: 10.1016/J.Mod.2008.06.009 |
0.303 |
|
| 2008 |
Falà F, Blalock WL, Tazzari PL, Cappellini A, Chiarini F, Martinelli G, Tafuri A, McCubrey JA, Cocco L, Martelli AM. Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-amine (A443654) in T-cell acute lymphoblastic leukemia. Molecular Pharmacology. 74: 884-95. PMID 18577685 DOI: 10.1124/Mol.108.047639 |
0.595 |
|
| 2007 |
Martelli AM, Tazzari PL, Evangelisti C, Chiarini F, Blalock WL, Billi AM, Manzoli L, McCubrey JA, Cocco L. Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside. Current Medicinal Chemistry. 14: 2009-23. PMID 17691943 DOI: 10.2174/092986707781368423 |
0.683 |
|
| 2007 |
McCubrey JA, Blalock WL, Tazzari PL, Cappellini A, Iacobucci I, Chiarini F, Abrams SL, Ottaviani E, Martinelli G, Tafuri A, Cocco L, Martelli AM, Fala F. The AKT Inhibitor, A443654, Induces Cell Cycle Arrest, Apoptosis and Synergizes with Chemotherapeutic Drugs in Multi-Drug Resistant T-Cell Acute Lymphoblastic Leukemia - A Novel Agent for Therapy of Drug Resistant ALL. Blood. 110: 3344-3344. DOI: 10.1182/Blood.V110.11.3344.3344 |
0.609 |
|
| 2006 |
Bennett RL, Blalock WL, Abtahi DM, Pan Y, Moyer SA, May WS. RAX, the PKR activator, sensitizes cells to inflammatory cytokines, serum withdrawal, chemotherapy, and viral infection. Blood. 108: 821-9. PMID 16861340 DOI: 10.1182/Blood-2005-11-006817 |
0.514 |
|
| 2004 |
Bennett RL, Blalock WL, May WS. Serine 18 phosphorylation of RAX, the PKR activator, is required for PKR activation and consequent translation inhibition. The Journal of Biological Chemistry. 279: 42687-93. PMID 15299031 DOI: 10.1074/Jbc.M403321200 |
0.466 |
|
| 2004 |
Shelton JG, Blalock WL, White ER, Steelman LS, McCubrey JA. Ability of the activated PI3K/Akt oncoproteins to synergize with MEK1 and induce cell cycle progression and abrogate the cytokine-dependence of hematopoietic cells. Cell Cycle (Georgetown, Tex.). 3: 503-12. PMID 15004527 DOI: 10.4161/Cc.3.4.813 |
0.843 |
|
| 2003 |
Shelton JG, Moye PW, Steelman LS, Blalock WL, Lee JT, Franklin RA, McMahon M, McCubrey JA. Differential effects of kinase cascade inhibitors on neoplastic and cytokine-mediated cell proliferation. Leukemia. 17: 1765-82. PMID 12970777 DOI: 10.1038/Sj.Leu.2403052 |
0.812 |
|
| 2003 |
Chang F, Steelman LS, Lee JT, Shelton JG, Navolanic PM, Blalock WL, Franklin RA, McCubrey JA. Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia. 17: 1263-93. PMID 12835716 DOI: 10.1038/Sj.Leu.2402945 |
0.838 |
|
| 2003 |
Blalock WL, Navolanic PM, Steelman LS, Shelton JG, Moye PW, Lee JT, Franklin RA, Mirza A, McMahon M, White MK, McCubrey JA. Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia. Leukemia. 17: 1058-67. PMID 12764369 DOI: 10.1038/Sj.Leu.2402925 |
0.847 |
|
| 2003 |
Shelton JG, Steelman LS, Lee JT, Knapp SL, Blalock WL, Moye PW, Franklin RA, Pohnert SC, Mirza AM, McMahon M, McCubrey JA. Effects of the RAF/MEK/ERK and PI3K/AKT signal transduction pathways on the abrogation of cytokine-dependence and prevention of apoptosis in hematopoietic cells. Oncogene. 22: 2478-92. PMID 12717425 DOI: 10.1038/Sj.Onc.1206321 |
0.844 |
|
| 2003 |
Chang F, Lee JT, Navolanic PM, Steelman LS, Shelton JG, Blalock WL, Franklin RA, McCubrey JA. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia. 17: 590-603. PMID 12646949 DOI: 10.1038/Sj.Leu.2402824 |
0.841 |
|
| 2003 |
Steelman LS, Blalock WL, Wang XY, Moye PW, Lee JT, Shelton JG, Navolanic PM, Davis JM, Knapp SL, Franklin RA, White MK, McCubrey JA. Elucidation of signal transduction pathways by retroviral infection of cells with modified oncogenes. Methods in Molecular Biology (Clifton, N.J.). 218: 221-52. PMID 12616724 DOI: 10.1385/1-59259-356-9:221 |
0.814 |
|
| 2003 |
Steelman LS, Blalock WL, Wang XY, Moye PW, Lee JT, Shelton JG, Navolanic PM, Davis JM, Knapp SL, Franklin RA, White MK, McCubrey JA. Elucidation of signal transduction pathways by transfection of cells with modified oncogenes. Methods in Molecular Biology (Clifton, N.J.). 218: 203-20. PMID 12616723 |
0.787 |
|
| 2003 |
Steelman LS, Blalock WL, Wang XY, Moye PW, Lee JT, Shelton JG, Navolanic PM, Davis JM, Knapp SL, Franklin RA, White MK, McCubrey JA. Fibroblastic, hematopoietic, and hormone responsive epithelial cell lines and culture conditions for elucidation of signal transduction and drug resistance pathways by gene transfer. Methods in Molecular Biology (Clifton, N.J.). 218: 185-201. PMID 12616722 DOI: 10.1385/1-59259-356-9:185 |
0.814 |
|
| 2003 |
Chang F, Steelman LS, Shelton JG, Lee JT, Navolanic PM, Blalock WL, Franklin R, McCubrey JA. Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review). International Journal of Oncology. 22: 469-80. PMID 12579299 DOI: 10.3892/Ijo.22.3.469 |
0.834 |
|
| 2002 |
Saleh OA, Blalock WL, Burrows C, Steelman LS, Doshi PD, McKearn JP, McCubrey JA. Enhanced ability of the progenipoietin-1 to suppress apoptosis in human hematopoietic cells. International Journal of Molecular Medicine. 10: 385-394. PMID 12239583 DOI: 10.3892/Ijmm.10.4.385 |
0.598 |
|
| 2001 |
McCubrey JA, Lee JT, Steelman LS, Blalock WL, Moye PW, Chang F, Pearce M, Shelton JG, White MK, Franklin RA, Pohnert SC. Interactions between the PI3K and Raf signaling pathways can result in the transformation of hematopoietic cells. Cancer Detection and Prevention. 25: 375-93. PMID 11531015 |
0.848 |
|
| 2001 |
McCubrey JA, Blalock WL, Saleh O, Pearce M, Burrows C, Steelman LS, Lee JT, Franklin RA, Oberhaus SM, Moye PW, Doshi PD, McKearn JP. Enhanced ability of daniplestim and myelopoietin-1 to suppress apoptosis in human hematopoietic cells. Leukemia. 15: 1203-16. PMID 11480562 DOI: 10.1038/Sj.Leu.2402167 |
0.569 |
|
| 2001 |
McCubrey JA, Steelman LS, Blalock WL, Lee JT, Moye PW, Chang F, Pearce M, Shelton JG, White MK, Franklin RA, Pohnert SC. Synergistic effects of pi3k/akt on abrogation of cytokine-dependency induced by oncogenic raf. Advances in Enzyme Regulation. 41: 289-323. PMID 11384752 DOI: 10.1016/S0065-2571(00)00021-2 |
0.799 |
|
| 2001 |
Blalock WL, Pearce M, Chang F, Lee JT, Pohnert SC, Burrows C, Steelman LS, Franklin RA, McMahon M, McCubrey JA. Effects of inducible MEK1 activation on the cytokine dependency of lymphoid cells. Leukemia. 15: 794-807. PMID 11368441 DOI: 10.1038/Sj.Leu.2402109 |
0.834 |
|
| 2001 |
Ruvolo PP, Gao F, Blalock WL, Deng X, Stratford May W. Ceramide Regulates Protein Synthesis by a Novel Mechanism Involving the Cellular PKR Activator RAX Journal of Biological Chemistry. 276: 11754-11758. PMID 11148216 DOI: 10.1074/Jbc.M011400200 |
0.484 |
|
| 2000 |
Weinstein-Oppenheimer CR, Blalock WL, Steelman LS, Chang F, McCubrey JA. The Raf signal transduction cascade as a target for chemotherapeutic intervention in growth factor-responsive tumors. Pharmacology & Therapeutics. 88: 229-79. PMID 11337027 DOI: 10.1016/S0163-7258(00)00085-1 |
0.834 |
|
| 2000 |
Weinstein-Oppenheimer C, Steelman LS, Algate PA, Blalock WL, Burrows C, Hoyle PE, Lee JT, Moye PW, Shelton JG, Franklin R, McCubrey JA. Effects of deregulated Raf activation on integrin, cytokine-receptor expression and the induction of apoptosis in hematopoietic cells. Leukemia. 14: 1921-38. PMID 11069028 DOI: 10.1038/Sj.Leu.2401926 |
0.831 |
|
| 2000 |
Blalock WL, Moye PW, Chang F, Pearce M, Steelman LS, McMahon M, McCubrey JA. Combined effects of aberrant MEK1 activity and BCL2 overexpression on relieving the cytokine dependency of human and murine hematopoietic cells. Leukemia. 14: 1080-96. PMID 10865974 DOI: 10.1038/Sj.Leu.2401793 |
0.689 |
|
| 2000 |
Moye PW, Blalock WL, Hoyle PE, Chang F, Franklin RA, Weinstein-Oppenheimer C, Pearce M, Steelman L, McMahon M, McCubrey JA. Synergy between Raf and BCL2 in abrogating the cytokine dependency of hematopoietic cells. Leukemia. 14: 1060-79. PMID 10865973 DOI: 10.1038/Sj.Leu.2401792 |
0.819 |
|
| 2000 |
McCubrey JA, Steelman LS, Moye PW, Hoyle PE, Weinstein-Oppenheimer C, Chang F, Pearce M, White MK, Franklin R, Blalock WL. Effects of deregulated RAF and MEK1 expression on the cytokine-dependency of hematopoietic cells. Advances in Enzyme Regulation. 40: 305-37. PMID 10828357 DOI: 10.1016/S0065-2571(99)00033-3 |
0.809 |
|
| 2000 |
Hoyle PE, Moye PW, Steelman LS, Blalock WL, Franklin RA, Pearce M, Cherwinski H, Bosch E, McMahon M, McCubrey JA. Differential abilities of the Raf family of protein kinases to abrogate cytokine dependency and prevent apoptosis in murine hematopoietic cells by a MEK1-dependent mechanism. Leukemia. 14: 642-56. PMID 10764150 DOI: 10.1038/Sj.Leu.2401720 |
0.701 |
|
| 2000 |
Blalock WL, Pearce M, Steelman LS, Franklin RA, McCarthy SA, Cherwinski H, McMahon M, McCubrey JA. A conditionally-active form of MEK1 results in autocrine tranformation of human and mouse hematopoietic cells. Oncogene. 19: 526-36. PMID 10698522 DOI: 10.1038/Sj.Onc.1203337 |
0.695 |
|
| 2000 |
McCubrey J, Blalock W, Pearce M, Steelman L, Moye P, Burrows C, Saleh O, Smith W, Doshi P, McKearn J. Enhanced ability of myelopoietins, dual receptor agonists for human IL-3 and g-csf receptors and the IL-3 receptor agonist, daniplestim, to suppress apoptosis and stimulate cytokine-inducible gene expression Experimental Hematology. 28: 39. DOI: 10.1016/S0301-472X(00)00209-5 |
0.56 |
|
| 2000 |
Pohnert S, Moye P, Blalock W, Steelman L, Burrows C, McMahon M, Mirza A, McCubrey J. Synergistic effects of akt on abrogation of cytokine-dependency induced by raf and mek Experimental Hematology. 28: 38. DOI: 10.1016/S0301-472X(00)00208-3 |
0.587 |
|
| 2000 |
McCubrey JA, Saleh OA, Navolanic PM, Pearce ML, Blalock WL, Steelman LS, Burrows CJ, Lee JT, Franklin RA, Doshi PD, McKearn JP. Enhanced ability of daniplestim and mpo-1 to suppress apoptosis and stimulate cytokine-inducible gene expression Blood. 96: 139b. |
0.727 |
|
| 2000 |
McCubrey JA, Shelton JG, Steelman LS, Pearce ML, Blalock WL, Cooke HJ, Kisser M. Enhanced ability of DT-IL3 to induce apoptosis in oncogene transformed human hematopoietic cells Blood. 96. |
0.72 |
|
| 2000 |
Blalock WL. Abrogation of cytokine-dependency by MEK1 involves the PI3 kinase-AKT pathway and is enhanced by BCL2 overexpression or aberrant AKT activation Blood. 96. |
0.588 |
|
| 1999 |
Blalock WL, Weinstein-Oppenheimer C, Chang F, Hoyle PE, Wang XY, Algate PA, Franklin RA, Oberhaus SM, Steelman LS, McCubrey JA. Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs. Leukemia. 13: 1109-66. PMID 10450743 DOI: 10.1038/Sj.Leu.2401493 |
0.837 |
|
| 1998 |
McCubrey JA, Steelman LS, Hoyle PE, Blalock WL, Weinstein-Oppenheimer C, Franklin RA, Cherwinski H, Bosch E, McMahon M. Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells. Leukemia. 12: 1903-29. PMID 9844921 DOI: 10.1038/Sj.Leu.2401215 |
0.851 |
|
| 1996 |
Steelman LS, Algate PA, Blalock WL, Wang XY, Prevost KD, Hoyle PE, McCubrey JA. Oncogenic effects of overexpression of the interleukin-3 receptor on hematopoietic cells. Leukemia. 10: 528-42. PMID 8642872 |
0.502 |
|
| Show low-probability matches. |